Man

Anil Prem Sadarangani Khianey

Director de Innovacion

Universidad de Los Andes

santiago, Chile

Líneas de Investigación


PhD. Oncologia ginecologica Innovación y transferencia tecnológica

Educación

  •  Biomedicina, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2008
  •  MBA, UNIVERSITY OF CALIFORNIA-SAN DIEGO. Estados Unidos, 2015
  •  Biologo, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2003

Experiencia Académica

  •   Profesor Full Time

    UNIVERSIDAD DE LOS ANDES

    Chile

    2015 - At present

Experiencia Profesional

  •   Post Doc Full Time

    university of california san diego

    San Diego, Estados Unidos

    2008 - 2015

  •   Subdirector de Desarrollo Tecnológico y Comercialización Full Time

    Universidad de los Andes

    Santiago, Chile

    2015 - 2018

  •   Director de Innovación Full Time

    Universidad de los Andes

    Santiago, Chile

    2018 - At present

Formación de Capital Humano


Director de Magíster en Innovación, Diplomado de Innovación, Minor de Innovación
de la Facultad de Ciencias Económicas y Empresariales


Difusión y Transferencia


Líder de programa de emprendimiento KALPA, KALPA SCIENCE y KUNAY en la Región de Antofagasta.


Premios y Distinciones

  •   RTTP

    ATTP

    Estados Unidos, 2018

    Certification como agente de transferencia tecnologica (RTTP)

  •   Beca Presidente Republica

    Gobierno de Chile

    Chile, 2008

    BEca otorgada por Presidente Bachelet

  •   Premio Transferencia Tecnológica

    CORPORACION DE FOMENTO DE LA PRODUCCION

    Chile, 2017

    Categoría Profesionales de la Transferencia Tecnológica


 

Article (19)

ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
GLI2 inhibition abrogates human leukemia stem cell dormancy
Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Telomerase Expression Abrogates Rapamycin-Induced Irreversible Growth Arrest of Uterine Fibroid Smooth Muscle Cells
A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches
Expression Profiling of Protein Tyrosine Kinases and Their Ligand Activators in Leiomyoma Uteri
Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase
Murine Xenograft Model for Human Uterine Fibroids: An In Vivo Imaging Approach
2-Methoxyestradiol Mediates Apoptosis Through Caspase-Dependent and Independent Mechanisms in Ovarian Cancer Cells But Not in Normal Counterparts
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium
TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract
In vivo and in vitro estrogenic and progestagenic actions of Tibolone
Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1
Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75

Abstract (5)

Establishment and characterization of a human uterine sarcoma cell line sensitive to TNF-related apoptosis inducing ligand plus doxorubicin.
2-methoxiestradiol induces apoptosis in gynecologic cancer cells but not in normal cell lines established from reproductive tissues.
2-Methoxyestradiol induces apoptosis in ovarian cancer cells but not in normal cells
Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells.
TNF-related apoptosis inducing ligand (TRAIL) induces apoptosis in endometrial cancer cells but not in normal cells.

Errata (1)

TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract (vol 12, pg 73, 2007)
25
Anil Sadarangani

Director de Innovacion

Innovacion

Universidad de Los Andes

santiago, Chile

13
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

7
Andres Carvajal

Investigador

INIA

Osorno, Chile

6
Angela Court

Asistente de Investigación

Medicina Nanoregenerativa

Universidad de Los Andes

Santiago, Chile

2
Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

2
Yolanda Vargas

Profesor Asociado

Producción Vegetal

UNIVERSIDAD DE CONCEPCIÓN

Chillán, Chile

1
Jorge Carvajal

Chief of Department

Obstetrics

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile